NR3C2 and myocardial infarction: Moreover, the LAMP (Leicester Acute Myocardial Infarction Peptide) Study [30] revealed a notable rise in plasma MR-proADM level following myocardial infarction, demonstrating a strong association with unfavorable cardiac outcomes.